BeOne Medicines Ltd.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
Country Switzerland
Business Address C/O BEONE MEDICINES I GMBH, BASEL, , 4051
Mailing Address C/O BEONE MEDICINES I GMBH, BASEL, , 4051
Phone 41-616851900
Fiscal Year End 1231
EIN 981209416
Financial Overview
FY2024
-$2.00B
Net Income
$5.92B
Total Assets
$6.13B
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 6, 2026 | View on SEC |
| 4 Insider stock transaction report | January 9, 2026 | View on SEC |
| 4 Insider stock transaction report | January 5, 2026 | View on SEC |
| 8-K Current report of material events | December 19, 2025 | View on SEC |
| 8-K Current report of material events | December 18, 2025 | View on SEC |
| 4 Insider stock transaction report | December 17, 2025 | View on SEC |
| 4 Insider stock transaction report | December 12, 2025 | View on SEC |
| 4 Insider stock transaction report | December 1, 2025 | View on SEC |
| 8-K Current report of material events | November 19, 2025 | View on SEC |
| 4 Insider stock transaction report | November 19, 2025 | View on SEC |
Insider Trading
STRONG SELL 4 insiders
34 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.